Depomed (DEPO): Favorable Court Ruling, Mostly Expected - Mizuho

October 3, 2016 6:47 AM EDT
Get Alerts DEPO Hot Sheet
Price: $23.39 -1.6%

Rating Summary:
    10 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 26 | Down: 29 | New: 38
Trade DEPO Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mizuho Securities analyst, Irina Koffler, reiterated her Buy rating on shares of DepoMed Inc (NASDAQ: DEPO) after the District Court ruled in favor of the company on the '364 and '593 patents which will prevent generic entry prior to patent expiry in December 2025.

This was largely expected but potential strategic acquirers can now properly value the company, which could expedite the sales process.

No change t the price target of $27.

For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.

Shares of DepoMed Inc closed at $24.97 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Litigation

Related Entities

Irina Koffler

Add Your Comment